[Epidemiological features of recurrent ENT mycoses and experience in their treatment with systemic antifungal drug intraconazole (orungamin)].
Eremina
N V
NV
Vladimirova
T Iu
TIu
Denisov
M V
MV
Egortseva
O N
ON
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015994:Incidence; D017964:Itraconazole / Q000008:administration & dosage*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome
D000935:Antifungal Agents; D017964:Itraconazole